David Ogilvie

David Ogilvie is a Global Product Leader at AstraZeneca, where they lead a cross-functional team in the R&D of a novel inhaled respiratory medication. Previously, they held roles in various capacities across esteemed organizations, including being a Doctor at the UK National Health Service and a Clinical Research Physician at Roche. They also gained experience as an Investment Manager at Inventages Venture Capital and as a Consultant at L.E.K. Consulting. David's educational background includes a Bachelor of Medicine, Bachelor of Surgery, and a Bachelor of Science in Pharmacology from UCL, as well as an MBA from London Business School.